Cyprotex, North American Science Associates deal
On Jan. 2, CRO Cyprotex acquired NAMSA's CeeTox Inc. division for about £630,000 ($1 million) in cash and up to £3.1 million ($5.1 million) in royalties. NAMSA retains a license for using CeeTox's in vitro...
